Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors - Wikidata - awgldk - TriplyDB

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

http://www.wikidata.org/entity/Q24683022

about

Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management Review of non-surgical treatment options for Peyronie's disease.Pharmacologic therapy for Peyronie's disease: what should we prescribe?Flow cytometric analysis of Pig-a gene mutation and chromosomal damage induced by procarbazine hydrochloride in CD-1 mice.The role of melatonin on chemotherapy-induced reproductive toxicity.

P2860

Q26830695-8C664970-72E2-46B1-89CB-40D9A139BAB0 Q37932386-E47B99F5-F370-43F8-93C6-E89890CE1051 Q38451060-E130DE69-66A0-4449-BE5D-B5F1F428680C Q43865749-034F2ECE-46B4-4823-B798-4F98C6C7C8CB Q48249082-FAE1F28D-E531-442E-8C70-92D269CE16FD

P2860

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

http://www.wikidata.org/entity/Q24683022

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@ast

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@en

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@nl

type

label

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@ast

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@en

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@nl

prefLabel

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@ast

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@en

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@nl

P1433

Q24683022-DFB12946-EEDA-4437-B101-421075101AF9

P1476

Q24683022-F8500BAE-4F5E-43E8-88E1-94BEC0617C10

P2093

Q24683022-1B19CB75-CBC2-44AA-919A-6AB1DCA717DA

Q24683022-4CD441C0-215B-4C16-8A32-B38498D98467

Q24683022-4D377535-9D8C-4513-A638-B5058C48FF8E

Q24683022-64228C10-866C-4250-9C99-4F6A36F6855E

P2860

Q24683022-0BBF6F0B-95CD-4CA1-9C94-9BEFAAD149CC

Q24683022-12EF2839-DEBD-4BE3-895C-AB3EF9F9A5F0

Q24683022-15FABE42-DD16-4354-8564-3D492614DEED

Q24683022-1A43E9F8-4C69-49DA-A3DF-173C579FC33E

Q24683022-1BA05DFA-4414-4924-BEE3-A3CD911EFC13

Q24683022-1CC315AD-7C60-453C-B094-248B5D578DBC

Q24683022-20E68494-628A-4C54-A432-FE6CCC6D1C5E

Q24683022-22ABCC93-C0FD-41D1-A3EB-D5B8CF3FF246

Q24683022-27FF033E-76FA-47BE-9223-6E76D4DB49C9

Q24683022-2A6DE699-8865-4DF8-84A0-25AC082F9EA1

P304

Q24683022-77C46FD2-2BC3-4EC5-A28B-BD234D96FD48

P31

Q24683022-2C2542DA-6840-4883-BFC1-B9F9BC03DA82

P356

Q24683022-23CACB60-D68B-4ECE-9C2C-4F1712E8B0A5

P407

Q24683022-727E58A7-1EC6-4ECE-B911-B3B623CAE32F

P433

Q24683022-730D4CB0-FA39-4662-939B-AD5744C9A128

P478

Q24683022-73793D01-EAE4-401A-9DBC-9553E0CCB366

P577

Q24683022-A2A92030-9937-4CD2-921F-A38DA83AF557

P5875

Q24683022-2CE9A43B-192F-4344-BA9B-4A3F4C110DD9

P698

Q24683022-7697C096-957E-4FEA-A887-95EC2102B96A

P921

Q24683022-D748FD7F-CE6B-4D5E-9F0F-1A477FA57684

P932

Q24683022-8E2DB8F1-BE2F-474A-8DD7-167026AB3129

P356

TCRM.2007.3.2.213

P1433

Therapeutics and Clinical Risk Management

P1476

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

@en

P2093

Jean-Luc Harrousseau

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Armand

http://www.w3.org/2001/XMLSchema#string

Lauren Abrey

http://www.w3.org/2001/XMLSchema#string

Vincent Ribrag

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?

ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi

Radiation-induced dementia in patients cured of brain metastases.

Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.

Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Ca

Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).

Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas

P304

213-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.2007.3.2.213

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5491027

http://www.w3.org/2001/XMLSchema#string

P698

18360630

http://www.w3.org/2001/XMLSchema#string

P921

P932

1936303

http://www.w3.org/2001/XMLSchema#string